Impact of Vaccine Manufacturing Announcement During Pandemic on The Stock Market Reaction of Pharmaceutical Companies
Abstract
The objective of this research is to identify whether there is a significant difference in the market reaction shown by the abnormal return and trading volume activity before and after the vaccine manufacturing announcement conducted by listed pharmaceutical companies around the world. The sample used in this research is listed pharmaceutical companies that conducted a vaccine manufacturing announcement during a pandemic, and the data collected is secondary data. This research uses the event study as its methodology with 3 event windows, which are one month before and after the announcement, ten days before and after the announcement, and five days before and after the announcement. The analysis of the normality test and paired difference test is conducted using the Wilcoxon Signed Rank Test with a significance level of 0.05. The result shows that there is no significant difference in both abnormal return and trading volume activity of the listed pharmaceutical companies before and after the vaccine manufacturing announcement. From this research, it can be concluded that the vaccine manufacturing announcement during a pandemic does not have a significant effect on the market reaction. To extend and further test the market reaction of pharmaceutical companies, future research could be done by exploring more on the effect of health-related news on all pharmaceutical companies, and the variables tested could be expanded
Downloads
Copyright (c) 2022 Cellina Trishana
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
